Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial

Tafenoquine is a novel 8-aminoquinoline antimalarial drug recently approved by the U.S. Food and Drug Administration (FDA) for the radical cure of acute Plasmodium vivax malaria, which is the first new treatment in almost 60 years. A population pharmacokinetic (POP PK) analysis was conducted with ta...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Antimicrob Agents Chemother
Egile Nagusiak: Thakkar, Nilay, Green, Justin A., Koh, Gavin C. K. W., Duparc, Stephan, Tenero, David, Goyal, Navin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2018
Gaiak:
Experimental Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201082/
https://ncbi.nlm.nih.gov/pubmed/30201820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00711-18
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak